Certain confidential information contained in this document, marked by [***], has been omitted because Roivant Sciences Ltd. (the “Company”) has determined that the information (i) is not material and (ii) contains personal information. COMMON SHARES...Common Shares Purchase Agreement • February 14th, 2022 • Roivant Sciences Ltd. • Pharmaceutical preparations • New York
This COMMON SHARES PURCHASE AGREEMENT is made and entered into as of February 14, 2022 (this “Agreement”), by and between CF Principal Investments LLC, a Delaware limited liability company (the “Investor”), and Roivant Sciences Ltd., a Bermuda exempted company limited by shares (the “Company”).
